Sero-prevalence of Hepatitis B Surface Antigen (HBsAg) amongst Pregnant Women Attending Antenatal Clinic at the Federal Medical Centre Umuahia, Abia State, Nigeria

Onwuakor C.E^1, , Eze V.C¹, Nwankwo I.U¹ and Iwu J.O²

¹Department of Microbiology, College of Natural Sciences, Michael Okpara University of Agriculture Umudike, Abia State, Nigeria

²Department of Accident & Emergency, Federal Medical Centre, Umuahia, Abia State, Nigeria

Cite this paper

Onwuakor C.E, Eze V.C, Nwankwo I.U and Iwu J.O. Sero-prevalence of Hepatitis B Surface Antigen (HBsAg) amongst Pregnant Women Attending Antenatal Clinic at the Federal Medical Centre Umuahia, Abia State, Nigeria. American Journal of Public Health Research. 2014; 2(6):255-259. doi: 10.12691/AJPHR-2-6-7

Abstract

Despite the existence of a safe and effective vaccine, Nigeria has remained a hyper-endemic area for hepatitis B virus infection, with estimated 12% of the total population being chronic carriers. Neonates who contact hepatitis B virus infection will have an almost 90% risk of developing chronic hepatitis B surface antigen (HBsAg) carrier state and chronic liver disease. The objectives of this study were to determine the sero-prevalence of hepatitis B surface antigen among pregnant women and identifying potential risk factors associated with the infection. This study involved a total of 350 pregnant women who attended antenatal at the Federal medical Centre, Umuahia, Abia State, Nigeria. Blood samples from all consenting pregnant women were collected. A structured pro forma designed for this purpose was used to obtain socio-demographic information and the presence of risk factors. Data collated was analyzed using GraphPad Prism statistical software with P<0.05 at 95% confidence interval. The results showed that HBsAg sero-prevalence rate of 7.1% was observed in all the pregnant women tested. Sero-prevalence of HBsAg amongst parturients were more in patients within their first trimesters (11.1%), Primigravida pregnant women (8.0%), women with history of dental or surgical procedures (34.0%) and multiple sexual partners (25.0%) and in women with no formal education (37.5%). An intermediate prevalence of HBsAg was identified which justifies the need for routine screening in pregnancy in order to identify and treat the infection, thus reducing the risk of transmission of the virus. Contraceptive options aimed at prevention of pregnancy and sexually transmitted infection (STI) should be encouraged.

Keywords

sero-prevalence, surface antigen, pregnant women, antenatal, Federal Medical Centre, Umuahia

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Goldstein, S,T., Zhou, F., Hadler, S.C., Bell, B.P., Mast, E.E and Margolis, H.S, “A mathematical model to estimate global hepatitis B disease burden and vaccination impact”, Int. J. Epidemol. 2005, 34(6): 1329-1339.
[2]	Burnett, R., Francois, G and Kew, G, “Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further action”. Liver Int. 2005, 25: 201-213.
[3]	Lavanchy, D, “Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures”. J. Viral Hep. 2004, 11: 97-107.
[4]	Maddrey, W.C, ‘Hepatitis B: an important public health issue”. J. Med. Virol. 2000, 61: 362-366.
[5]	Kao, J.H, “Diagnosis of hepatitis B virus infection through serological and viral markers”. Expert Rev. Gastroenterol. Hepatol. 2008, 2(4): 504-62.
[6]	Eke, A.C., Eke, U.A., Okafor, C.I., Ezebialu, I.U and Ogbuagu, C, “Prevalence, correlates and pattern of Hepatitis B surface antigen in a low resource setting”. Virol. J. 2011, 8: 12.
[7]	El-Magrahe, H., Furarah, A.R., El-Figih, K., El-Urshfany, S, and Ghenghesh, K.S, “Maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Tripoli, Libya”. J. Infect. Dis. Dev. Ctries, 2010, 4: 168-170.
[8]	Mbaawuaga, E.M., Enenebeaka, M.N.O., Okopi, J.A and Damen, J.G, “Hepatitis B virus infection (HBV) among pregnant women in Makurdi, Nigeria”. Afr. J. Biol. Res. 2008, 11:155-159.
[9]	Ugwuja, E.I., “Seroprevalence of Hepatitis B surface antigen and liver function tests among adolescents in Abakaliki, Southern Nigeria”. Int. J. Trop. Med. 2010, 6(2):1-6.
[10]	Obi, C.L., Nnatu, S.N., Anyiwo, C.E., Agbonlahor, D.E., Esuneh, F.I and Karpos, A, “A comparison of HIV seropositivity and Hepatitis B surface antigenaemia (HBsAg) among the same group of apparently healthy pregnant women in Lagos, Nigeria: a preliminary report”. Viral Immunol. 1993, 6(1): 43-47.
[11]	Ezegbudo, C.N., Agbonlahor, D.E., Nwobu, G.O., Igwe, C.U., Agba, M.I and Okpala, H.O, “The seroprevalence of Hepatitis B surface antigen and Human immunodeficiency virus (HIV) among pregnant women in Anambra State”. Shiraz E-medical J. 2004, 5(2): 1-8.
[12]	Baba, M.M., Onwuka, I.S and Baba, S.S, “Hepatitis B and C infections among pregnant women in Maiduguri, Nigeria”. Central Eur. J. Pub. Health. 1999, 7(2): 60-62.
[13]	Chen, C and Chang, M, “Hepatitis B and pregnancy; The scientific basis for perinatal prevention”. Cambridge J. Online, 2010, 21: 89-113.
[14]	Pennap, G.R., Osanga, E.T and Ubam, A, “Seroprevalence of hepatitis B surface antigen among pregnant women attending antenatal clinic in Federal Medical Center, Keffi, Nigeria’. Res. J. Med. Sci. 2011, 51(2):80-82.
[15]	Akani, C.I., Ojule, A.C., Opurum, H.C and Ejilemele, A.A “Seroprevalence of HbsAg in pregnant women in Port Harcourt, Nigeria”. Postgrad Med. J. 2005, 12 (4): 266-270.
[16]	Ojo, O.O and Anibijuwon, I.I, “Determination of antibodies to hepatitis B virus in pregnant women in Akure, Ondo state, Nigeria”. Cont. J. Microbiol. 2009, 3: 6-10.
[17]	Jatau, E.D and Yabaya, A, “Seroprevalence of hepatitis B virus in pregnant women attending a clinic in Zaria, Nigeria”. Sci. World J. 2009, 7-9.
[18]	Ndams, I.S., Joshua, I.A., Luka, S.A and Sadiq, H.O, “Epidemiology of hepatitis B infection among pregnant women in Minna, Nigeria”. Sci. World J. 2008, 3(3): 5-8.
[19]	Duncan, M.E., Tibaus, G and Pelger, A, “Prevalence and significance of sexually transmitted diseases among women attending clinics in Addis Ababa”. Ethiop. J. Health Dev. 1995, 12: 31-40.
[20]	Candotti, D., Danso, K and Allain, J, “Maternal transmission of hepatitis B virus genotype E in Ghana, West Africa”. J. Gen. Virol. 2007, 88: 2686-2695.
[21]	WHO/EPI, “Protocol for assessing prevalence of hepatitis B infection in antenatal patients’. 1990, WHO/EPI/GEN/90.6.
[22]	Awole, M and Gebre-selassie, S, “Seroprevalence of hepatitis B surface antigen and its risk factors among pregnant women in Jimma, South-west Ethiopia”. Ethiop. J. Health Dev. 2005, 19(1): 45-50.
[23]	Ahmedin, J., Taylor, m and Ram, C.T, “A new section in cancer offering timely and targeted information”. Can. J. Clin. 2004, 54: 23-25
[24]	Chakravati, A., Rawat, D and Jarin, M, “A study of the perinatal trans-mission of the hepatitis B virus”. Ind. J. Med. Microbiol. 2005, 23: 128-130.
[25]	Wiseman, E., Fraser, M.A., Holden, S., Glass, A., Bronwynne, L.K., Leon, G.H., Michael, W.M., Ayres, A and Locarnini, S.A, “Perinatal transmission of hepatitis B virus: an Australian experience”. Med. J. Aust. 2009, 190(9): 489-492.